Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA

Journal of Autoimmunity

Volumn 14, Issue 1, 2000, Pages 83-97

  Eggena, Mark ^a   Cohavy, Offer ^a   Parseghian, Missag H ^b   Hamkalo, Barbara A ^b   Clemens, Dan ^a   Targan, Stephan R ^c   Gordon, Lynn K ^a   Braun, Jonathan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Histone H1; Inflammatory bowel disease; Monoclonal antibodies; PANCA; Ulcerative colitis

Indexed keywords

ANTIGEN; HISTONE H1; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AMINO ACID SEQUENCE; ANTIBODY DETECTION; ANTIGEN EXPRESSION; ARTICLE; CAPILLARY ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE MARKER; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; NEUTROPHIL; PEPTIDE MAPPING; PRIORITY JOURNAL; PROTEIN DEGRADATION; ULCERATIVE COLITIS; WESTERN BLOTTING;

EID: 0033952860     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1999.0340     Document Type: Article

References (67)

1. Abreu-Martin M.T., Targan S.R. Regulation of immune responses of the intestinal mucosa. Critical. Rev. Immunol. 16:1996;277-309.
2. Saxon A., Shanahan F., Landers C., Ganz T., Targan S.R. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J. Allergy Clin. Immunol. 86:1990;202-210.
3. Duerr R.H., Targan S.R., Landers C.J., Sutherland L.R., Shanahan F. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 100:1991;1590-1596.
4. Shanahan F., Duerr R.H., Rotter J.I., Yang H.-Y., Sutherland L.R., McElree C., Landers C.J., Targan S.R. Neutrophil autoantibodies in ulcerative colitis: familial aggregation and genetic heterogeneity. Gastroenterology. 103:1992;456-461.
5. Yang H.-Y., Rotter J.I., Toyoda H., Landers C., Tyan D., McElree C.K., Targan S.R. Ulcerative colitis: A genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers. J. Clin. Invest. 92:1993;1080-1084.
6. Seibold F., Slametschka D., Gregor M., Weber P. Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 107:1994;532-536.
7. Billing P., Tahir S., Calfin B., Gagne G., Cobb L., Targan S.R., Vidrich A. Nuclear localization of the antigen detected by ulcerative colitis-associated perinuclear antineutrophil cytoplasmic antibodies. Am. J. Pathol. 147:1995;979-987.
8. Vidrich A., Lee J., James E., Cobb L., Targan S.R. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: ulcerative colitis, type 1 autoimmune hepatitis, and primary sclerosing cholangitis. J. Clin. Immunol. 15:1995;293-299.
9. Eggena M., Targan S.R., Iwanczyk L., Vidrich A., Gordon L.K., Braun J. Phage display cloning and characterization of an immunogenetic marker (perinuclear anti-neutrophil cytoplasmic antibody) in ulcerative colitis. J. Immunol. 156:1996;4005-4011.
10. Barbas C.F., Kang A.S., Lerner R., Benkovic S.J. Assembly of combinatorial antibody libraries on phage surfaces: The gene III site. Proc. Natl. Acad. Sci. U S A. 88:1991;7978-7982.
11. Parseghian M., Harris D.A., Rishwain D.R., Hamkalo B.A. Characterization of a set of antibodies specific for three human histone H1 subtypes. Chromosoma. 103:1994;198-208.
12. Parseghian M., Clark R.F., Hauser L.J., Dvorkin N., Harris D.A., Hamkalo B.A. Fractionation of human H1 subtypes and characterization of a subtype-specific antibody exhibiting non-uniform nuclear staining. Chromosome Res. 1:1993;127-134.
13. Martin S.J., Bradley J.G., Cotter T.G. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunol. 79:1990;448-456.
14. Jeno P., Mini T., Moes S., Hintermann E., Horst M. Internal sequences from proteins digested in polyacrylamide gels. Annl. Biochem. 224:1995;75-83.
15. Rosenfeld J., Capdevielle J., Guilemot J.C., Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Annl. Biochem. 203:1992;173-179.
16. Smith D.J., Salmi M., Bono P., Hellman J., Leu T., Jalkanen S. Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188:1998;17-27.
17. Hellman U., Wernstedt C., Gonez J., Heldin C.H. Improvement of an 'In-Gel' digestion procedure for the micropreparation of internal protein fragments for amino acid sequencing. Annal. Biochem. 224:1995;451-456.
18. Altschul S.F., Gish W., Miller W., Meyers E.W., Lippman D.J. Basic local alignment search tool. J. Mol. Biol. 215:1990;403-410.
19. Parseghian M.H., Henschen A.H., Kriegltein K.G., Hamkalo B.A. A proposal for a coherent mammalian histone H1 nomenclature correlated with amino acid sequences. Protein Sci. 3:1994;575-587.
20. Prigozy T.I., Sieling P.A., Clemens D., Stewart P.L., Behar S.M., Porcelli S.A., Brenner M.B., Modlin R.L., Kronenberg M. The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1b molecules. Immunity. 6:1997;187-197.
21. Mazrimas J.A., Balhorn R., Hatch F.T. Separation of satellite DNA and main band chromatin from mouse brain. Nucleic Acids Res. 7:1979;935-941.
22. Linder H., Wurm M., Dirschlmayer A., Sarg B., Hellinger W. Application of high performance capillary electrophoresis to the analysis of H1 histones. Electrophoresis. 14:1993;480-485.
23. Weaver V.M., Lach B., Walker P.R., Sikorska M. Role of proteolysis in apoptosis: involvement of serine proteases in internucleosomal DNA fragmentation in immature thymocytes. Biochemistry Cell Biology. 71:1993;488-500.
24. Staynov D.Z., Crane-Robinson C. Footprinting of linker histones H5 and H1 on the nucleosome. Embo. J. 7:1988;3685-3691.
25. Minota S., Morino N., Sakurai H., Yamada A., Yazaki Y. Interrelationship between autoepitope, DNA-binding domain, and CRP-binding domain on a histone H1 molecule. Clin. Immunol. Immunopathol. 66:1993;269-271.
26. Guan K.-L., Dixon J.E. Eukaryotic proteins expressed in Escherichia coli: An improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Annal. Biochem. 192:1991;262-267.
27. Zlatanova J., Doenecke D. Histone H1o: a major player in cell differentiation. FASEB J. 8:1994;1260-1268.
28. Thielemans K., Maloney D.G., Meeker T., Fujimoto J., Doss C., Warnke R.A., Bindl J., Gralow J., Miller R.A., Levy R. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas. J. Immunol. 133:1984;495-501.
29. Kallenberg C.G., Mulder A.H., Tervaert J.W. Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am. J. Med. 93:1992;675-682.
30. Zlatanova J.S. Immunochemical approaches to the study of histone H1 and high mobility group chromatin proteins. Mol. Cell. Biochem. 92:1990;1-12.
31. Banchev T.B., Srebreva L.N., Zlatanova J.S. Accessibility of histone H1o and its structural domains to antibody binding in extended and folded chromatin. Mol. Cell. Biochem. 95:1990;167-175.
32. Hutchinson N., Weintraub H. Colocalization of DNAse I sensitive sequences to specific regions of interphase nuclei. Cell. 43:1985;471-479.
33. Krystek A., Puck T. The spatial distribution of exposed nuclear DNA in normal, cancer, and reverse-transformed cells. Proc. Natl. Acad. Sci. U S A. 87:1990;87-6560.
34. Clark R.F., Cho K.W.Y., Weinmann R., Hamkalo B.A. Preferential distribution of active RNA polymerase II molecules in the nuclear periphery. Gene Exp. 1:1991;61-69.
35. Pruss D., Bartholomew B., Persinger J., Hayes J., Arents G., Moudrianakis E.N., Wolffe A.P. An asymmetric model for the nucleosome: a binding site for linker histones inside the DNA gyres. Science. 274:1996;614-617.
36. Bradbury E.M. Reversible histone modifications and the chromosome cell cycle. Bioessays. 14:1992;9-16.
37. Hohmann P. Species- and cell-specific expression of H1 histones in tissue culture cells. Arch. Biochem. Biophys. 205:1980;198-205.
38. Voelkel-Johnson C., Entingh A.J., Wold W.S.M., Gooding L.R., Laster S.M. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J. Immunol. 154:1995;1707-1716.
39. Doenecke D., Albig W., Bouterfa H., Drabent B. Organization and expression of H1 histone and H1 replacement histone genes. J. Cell. Biochem. 54:1994;423-431.
40. Baxevanis A.D., Landsman D. Histone sequence database: A compilation of highly-conserved nucleoprotein sequences. Nucleic Acids Res. 24:1996;245-247.
41. Sobajima J., Ozaki S., Osakada F., Uesugi H., Shirakawa H., Yoshida M., Nakao K. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (p- ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2. Clin. Exp. Immunol. 107:1997;135-140.
42. Sobajima J., Ozaki S., Uesugi H., Osakada F., Shirakawa H., Yoshida M., Nakao K. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC). Clin. Exp. Immunol. 111:1998;402-407.
43. Reumaux D., Meziere C., Colombel J.-F., Duthilleul P., Muller S. Distinct production of autoantibodies to nuclear components in ulcerative colitis and in Crohn's disease. Clin. Immunol. Immunopathol. 77:1995;349-357.
44. Stemmer C., Briand J.-P., Muller S. Mapping of linear epitopes of human histone H1 recognized by rabbit anti-H1/H5 antisera and antibodies from autoimmune patients. Molec. Immunol. 31:1994;1037-1046.
45. Hauschild S., Schmitt W.H., Csernok E., Flesch B.K., Rautmann A., Gross W.L. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv. Exp. Med. Biol. 336:1993;245-250.
46. Bosch X., Llena J., Collado-Vides J., Font J., Mirapeix E., Ingelmo M., Munoz-Gomez J., Urbano-Marquez A. Occurrence of antineutrophil cytoplasmic and antineutrophil (peri)nuclear antibodies in rheumatoid arthritis. J. Rheumatol. 22:1995;2038-2044.
47. Ecklund S.R., Saluta G.S., Agudelo C.A., Pisko E.J. Antineutrophil cytoplasmic antibodies: clinical characteristics of 10 patients with the perinuclear pattern of immunofluorescence on ANCA testing. Southern Med. J. 85:1992;132-136.
48. Pauls J.D., Silverman E.D., Laxer R.M., Fritzler M. Antibodies to histones H1 and H5 in sera of patients with juvenile rheumatoid arthritis. Arth. Rheum. 32:1989;877-885.
49. Wesierska-Gadek J., Penner E., Lindner H., Hitchman E., Sauermann G. Autoantibodies against different histone H1 subtypes in systemic lupus erythematosus sera. Arth. Rheum. 33:1990;1273-1280.
50. Cohen M.K., Pollard K.M., Webb J. Antibodies to histones in systemic lupus erythematous: prevalence, specificity, and relationship to clinical and laboratory features. Annals Rheum. Dis. 51:1992;641-643.
51. Costa O., Monier J.C. Antihistone antibodies detected by ELISA and immunoblotting in systemic lupus erythematosus and rheumatoid arthritis. J. Rheumatol. 13:1986;722-725.
52. Folwaczny C., Noehl N., Endres S.P., Heldwein W., Loeschke K., Fricke H. Antinuclear autoantibodies in patients with inflammatory bowel disease - High prevalence in first-degree relatives. Dig. Dis. Sci. 42:1997;1593-1597.
53. Miller B.J., Pauls J.D., Fritzler M.J. Human monoclonal antibodies demonstrate polyreactivity for histones and the cytoskeleton. J. Autoimmunity. 4:1991;665-670.
54. Rubin, R.L. 1992, Antihistone antibodies, Systemic Lupus Erythematous, R.G. Lahita, Churchill Livingstone, New York, 247, 255.
55. Esnault V.L., Short A.K., Audrain M.A., Jones S., Martin S.J., Skehel J.M., Lockwood C.M. Autoantibodies to lactoferrin and histone in systemic vasculitis identified by anti-myeloperoxidase solid phase assays. Kidney International. 46:1994;153-156.
56. Muller S., Richalet P., Laurent-Crawford A., Barakat S., Rivière Y., Porrot F., Chamaret S., Briand J.P., Montagnier L., Hovanessian A. Autoantibodies typical of non-organ-specific autoimmune diseases in HIV-seropositive patients. AIDS. 6:1992;933-942.
57. Morino N., Sakurai H., Yamada A., Yazaki Y., Minota S. Rabbit anti-chromatin antibodies recognize similar epitopes on a histone H1 molecule as lupus autoantibodies. Clin. Immunol. Immunopathol. 77:1995;52-58.
58. Sartor R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am. J. Gastroenterol. 92:1997;S5-S11.
59. Mizoguchi E., Mizoguchi A., Chiba C., Niles J.L., Bhan A.K. Antineutrophil cytoplasmic antibodies in T-cell receptor alpha-deficient mice with chronic colitis. Gastroenterology. 113:1997;1828-1835.
60. Seibold F., Brandwein S., Simpson S., Terhorst C., Elson C.O. pANCA represents a cross-reactivity to enteric bacterial antigens. J. Clin. Immunol. 18:1998;153-160.
61. Vretou E., Eliades P., Psarrou E., Kouvatsou R. Eucaryotic cell components that bind to chlamydial elementary bodies: the histones. FEMS Microbiol. Lett. 70:1992;225-231.
62. Goyard S. Identification and characterization of BpH2, a novel histone H1 homolog in Bordetella pertussis. J. Bacteriol. 178:1996;3066-3071.
63. Painbeni E., Caroff M., Rouviere-Yaniv J. Alterations of the outer membrane composition in Escherichia coli lacking the histone-like protein HU. Proc. Natl. Acad. Sci. U S A. 94:1997;6712-6717.
64. Zhivotovsky B., Burgess D.H., Orrenius S. Proteases in apoptosis. Experientia. 52:1996;968-978.
65. Jaeschke H., Fisher M.A., Lawson J.A., Simmons C.A., Farhood A., Jones D.A. Activation of caspase 3 (CPP32)-like proteases is essential for TNF-alpha-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J. Immunol. 160:1998;3480-3486.
66. Muller S., Chaix M.L., Briand J.P., van Regenmortel M.H.V. Immunogenicity of free histones and of histones complexed with RNA. Molec. Immunol. 28:1991;763-772.
67. Bell D.A., Morrison B., VandenBygaart P. Immunogenic DNA-related factors. Nucleosomes spontaneously released from normal murine lymphoid cells stimulated proliferation and immunoglobulin synthesis of normal mouse lymphocytes. J. Clin. Invest. 85:1990;1487-1496.